When the Lupus Foundation of America became aware of a hydroxychloroquine (Plaquenil®) shortage, we set out to discover the root of problem. While we still have limited information, we want to alert our constituents to the facts of the situation.
With the steadily rising temperatures come the first Walk to End to Lupus Now™ events of 2015. Whether you’ve been involved for years or will be participating for the first time, these events are an incredible way to experience firsthand the power of the movement to end lupus.
At the 2014 American College of Rheumatology Annual Scientific Meeting, Dr. Sara K. Tedesch presented her study on the relationship between lupus activity prior to getting pregnant and during pregnancy. The Lupus Foundation of America conducted a Q&A with Dr. Tedeschi about her study.
Lupus-related kidney inflammation (lupus nephritis) is one of the most common and serious complications of lupus. However, a new study demonstrates that an understudied inflammation pathway in lupus may bring researchers closer to developing a novel blood-based test that could predict the progression of kidney failure.
How will you show your love for someone special this Valentine's Day? National board member Fran Tsimoyianis chooses to support the Lupus Foundation of America because someone she loves has lupus.
At a scientific symposium in San Francisco last month, some of the country’s foremost experts on lupus shared their insights about the current state of lupus clinical trial design. Read more.
Jessica Molon and Jen Strom are friends, former roommates and most importantly, they are each other’s support system. Jen has been living with lupus for more than four years and Jessica was recently diagnosed with a benign brain tumor.
February 2015 - Dr. Hazel L. Breland, PhD, OTR/L answered your questions about exercise and lupus as part of the Ask the Experts program.